Gossamer Bio (GOSS) Stock: Buy, Sell, or Hold?
GOSS - Gossamer Bio, Inc. Common Stock
$10.73
10.59 (7435.11%)
▲
5d:
+6010.48%
30d:
+5941.67%
90d:
+5948.48%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When GOSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: GOSS is 5861.1% above its trading range ($0.18). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: GOSS is 5861.1% above its trading range ($0.18). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GOSS is currently trading at $10.73, which is considered oversold relative to its 30-day fair value range of $0.16 to $0.18.
Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $0.14, while resistance sits at $12.52. The stock is showing strong short-term momentum, up 7435.1% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $1.66. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $0.14, while resistance sits at $12.52. The stock is showing strong short-term momentum, up 7435.1% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $1.66. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.16 -
$0.18
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
GOSS is technically overbought (RSI 99). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7435.1%)
- BEARISH: Trading 84.6% above Wall St target ($1.66)
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
- WARNING: Recommendation downgraded due to 5861.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.16 -
$0.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.14
Resistance Level
$12.52
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-54.97
Wall Street Target
$1.66
(-84.6%)
Revenue Growth (YoY)
-19.6%
Profit Margin
-235.0%
Share & Embed Analysis
Last updated: September 12, 2026 11:09 PM ET
Data refreshes hourly during market hours. Next update: 12:09 AM
Data refreshes hourly during market hours. Next update: 12:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced GOSS Option Strategies
Professional options setups generated by AI based on today's GOSS price and gamma walls.
